Holdings Channel
Home Articles Latest Filings All Funds Stocks Being Bought Stocks Being Sold Insider Buying
Play Video: The Importance of Insider Buying


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
THRX — Current Quote
Quotes delayed 20 minutes

Email EnvelopeFree THRX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

THRX — Performance
More Insider Buying
Other companies seeing insider buying close in time to when the THRX Insider Buying occurred are:

VBIV Insider Buying
RKFL Insider Buying
BMC Insider Buying
EQS Insider Buying
PGZ Insider Buying
LMT Insider Buying
ACGN Insider Buying
BYD Insider Buying
SVRA Insider Buying
SLGD Insider Buying

THRX insider buying image
The table below summarizes the most recent THRX insider buying information, with links below the price to see the CAGR achieved by each insider on their purchases. As the saying goes on Wall St., there are many possible reasons to sell a stock, but only one reason to buy. Watch the importance of insider buying video for more information about why THRX insider buys are important for investors to follow.
DateInsiderPriceAmount
7-17-2023
Insider Buy		 Carl L. Gordon
Director and >10% Owner		 $3.05
CAGR » 		$1,463,792.60
479,932 shares
7-17-2023
Insider Buy		 ORBIMED ADVISORS LLC
Director and >10% Owner		 $3.05
CAGR » 		$1,463,792.60
479,932 shares
7-17-2023
Insider Buy		 Foresite Capital Management V, LLC
>10% Owner		 $2.97
CAGR » 		$2,079,000.00
700,000 shares
12-29-2022
Insider Buy		 Foresite Capital Management V, LLC
>10% Owner		 $5.00
CAGR » 		$2,500,000.00
500,000 shares
11-30-2022
Insider Buy		 Bradford D. Dahms
Chief Financial Officer		 $6.66
CAGR » 		$10,000.07
1,502 shares
11-7-2022
Insider Buy		 Carl L. Gordon
Director and >10% Owner		 $5.21
CAGR » 		$1,000,320.00
192,000 shares
11-7-2022
Insider Buy		 ORBIMED ADVISORS LLC
Director and >10% Owner		 $5.21
CAGR » 		$1,000,320.00
192,000 shares
12-30-2022
Insider Buy		 Donald J. Hayden Jr.
Director		 $5.00
CAGR » 		$49,989.11
10,000 shares
11-11-2022
Insider Buy		 Timothy P. Clackson
President and CEO		 $6.80
CAGR » 		$16,995.00
2,500 shares
1-21-2022
Insider Buy		 ORBIMED ADVISORS LLC
Director and >10% Owner		 $9.97
CAGR » 		$1,578,717.49
158,417 shares
1-21-2022
Insider Buy		 Carl L. Gordon
Director and >10% Owner		 $9.97
CAGR » 		$1,578,717.49
158,417 shares
1-13-2022
Insider Buy		 ORBIMED ADVISORS LLC
Director and >10% Owner		 $9.90
CAGR » 		$442,750.42
44,717 shares
1-13-2022
Insider Buy		 Carl L. Gordon
Director and >10% Owner		 $9.90
CAGR » 		$442,750.42
44,717 shares
12-21-2021
Insider Buy		 Bradford D. Dahms
Chief Financial Officer		 $10.15
CAGR » 		$20,000.00
1,970 shares
12-21-2021
Insider Buy		 Timothy P. Clackson
President and CEO		 $9.76
CAGR » 		$25,381.46
2,600 shares
10-12-2021
Insider Buy		 ORBIMED ADVISORS LLC
Director and >10% Owner		 $16.00
CAGR » 		$10,000,000.00
625,000 shares
10-12-2021
Insider Buy		 Springs Capital Management LP Rock
>10% Owner		 $16.00
CAGR » 		$4,000,000.00
250,000 shares
10-12-2021
Insider Buy		 William Shakespeare
See Remarks		 $16.00
CAGR » 		$10,000.00
625 shares
10-12-2021
Insider Buy		 Carl L. Gordon
Director and >10% Owner		 $16.00
CAGR » 		$10,000,000.00
625,000 shares
10-12-2021
Insider Buy		 Omega Fund VI, L.P.
 $16.00
CAGR » 		$3,000,000.00
187,500 shares
8-7-2015
Insider Buy		 Plc Glaxosmithkline
>10% Owner		 $3485841.04
CAGR » 		$856,917,331,181.12
245,828 shares
5-11-2015
Insider Buy		 Plc Glaxosmithkline
>10% Owner		 $1369264.00
CAGR » 		$117,180,243,856.00
85,579 shares
3-2-2015
Insider Buy		 Plc Glaxosmithkline
>10% Owner		 $1673692.44
CAGR » 		$155,107,773,184.56
92,674 shares
11-4-2014
Insider Buy		 Plc Glaxosmithkline
>10% Owner		 $12786524.16
CAGR » 		$10,644,218,756,137.00
832,456 shares
8-11-2014
Insider Buy		 Plc Glaxosmithkline
>10% Owner		 $3912271.66
CAGR » 		$675,457,614,370.66
172,651 shares
5-9-2014
Insider Buy		 Plc Glaxosmithkline
>10% Owner		 $8544835.30
CAGR » 		$2,715,292,313,281.00
317,770 shares
2-11-2014
Insider Buy		 Plc Glaxosmithkline
>10% Owner		 $12850698.95
CAGR » 		$4,397,881,850,959.55
342,229 shares
10-29-2013
Insider Buy		 Plc Glaxosmithkline
>10% Owner		 $4913613.18
CAGR » 		$641,093,852,434.14
130,473 shares
7-30-2013
Insider Buy		 Plc Glaxosmithkline
>10% Owner		 $111850855.50
CAGR » 		$342,756,544,550,188.00
3,064,407 shares
4-30-2013
Insider Buy		 Plc Glaxosmithkline
>10% Owner		 $6699215.43
CAGR » 		$1,296,720,236,277.09
193,563 shares
2-15-2013
Insider Buy		 Plc Glaxosmithkline
>10% Owner		 $2567089.81
CAGR » 		$299,135,274,289.87
116,527 shares
8-3-2012
Insider Buy		 Plc Glaxosmithkline
>10% Owner		 $28.21
CAGR » 		$8,923,782.14
316,334 shares
5-16-2012
Insider Buy		 Plc Glaxosmithkline
>10% Owner		 $21.29
CAGR » 		$212,887,000.00
10,000,000 shares
2-14-2012
Insider Buy		 Plc Glaxosmithkline
>10% Owner		 $18.12
CAGR » 		$1,603,040.16
88,468 shares
11-1-2011
Insider Buy		 Plc Glaxosmithkline
>10% Owner		 $22.23
CAGR » 		$1,298,476.53
58,411 shares
8-2-2011
Insider Buy		 Plc Glaxosmithkline
>10% Owner		 $19.71
CAGR » 		$2,019,604.86
102,466 shares
5-3-2011
Insider Buy		 Plc Glaxosmithkline
>10% Owner		 $25.60
CAGR » 		$6,689,254.40
261,299 shares
11-1-2011
Insider Buy		 Plc Glaxosmithkline
>10% Owner		 $22.23
CAGR » 		$1,298,476.53
58,411 shares
8-2-2011
Insider Buy		 Plc Glaxosmithkline
>10% Owner		 $19.71
CAGR » 		$2,019,604.86
102,466 shares
5-3-2011
Insider Buy		 Plc Glaxosmithkline
>10% Owner		 $25.60
CAGR » 		$6,689,254.40
261,299 shares
2-18-2011
Insider Buy		 Plc Glaxosmithkline
>10% Owner		 $23.70
CAGR » 		$3,608,988.60
152,278 shares
11-29-2010
Insider Buy		 Plc Glaxosmithkline
>10% Owner		 $22.50
CAGR » 		$129,375,000.00
5,750,000 shares

Also See: Institutional Holders of THRX
Also See: SEC filings

THRX Performance Since Insider Purchase
Below we present the annualized performance delivered by THRX stock since 7-17-2023 (the date of the most recent insider purchase). The performance of the investment from the time THRX insider buying occurred is the ultimate test of whether insiders were right about THRX being a good buy.

Growth of $10,000.00
Without Dividends Reinvested
Start date: 07/18/2023
End date: 02/14/2024
Start price/share: $2.82
End price/share: $4.06
Dividends collected/share: $0.00
Total return: 43.97%
Annualized Gain: 76.06%
Starting investment: $10,000.00
Ending investment: $14,397.00
Years: 0.58

THRX Insider Buying

This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.), and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these categories, but instead file their holdings quarterly on the latest form 13F filings. While recent THRX insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).

Also See: Funds Holding THRX

THRX Insider Buying | www.HoldingsChannel.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in Holdings Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent. Contact Holdings Channel; Meet Our Editorial Staff.